Welcome to our dedicated page for Alphatec Hldgs news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Hldgs stock.
Alphatec Holdings, Inc. (Nasdaq: ATEC) is a spine-focused medical device company whose news flow centers on spine surgery innovation, financial performance, and strategic collaborations. Through subsidiaries such as Alphatec Spine, Inc., EOS imaging S.A.S., and SafeOp Surgical, Inc., ATEC regularly issues updates on procedural technologies, imaging platforms, and neuro-monitoring systems that support its goal of revolutionizing spine surgery.
Investors and clinicians following ATEC news can expect frequent announcements of quarterly and annual financial results, including commentary on surgical revenue, EOS revenue, adjusted EBITDA, and free cash flow. The company often pairs its earnings releases with updated full-year outlooks, highlighting trends in surgical volume growth, new surgeon adoption, and the performance of its procedural ecosystems such as PTP™ and LTP™.
ATEC’s news stream also features product and platform launches, such as the commercial introduction of the PTP™ Corpectomy system, which expands its Prone TransPsoas approach to complex thoracolumbar pathologies. These announcements provide detail on systems like the Sigma™ LIF Corpectomy Access System, Ascend™ NanoTec™ Vertebral Body Replacement System, and SafeOp™ Neural InformatiX™ System, illustrating how the company integrates access, implants, and neuro-monitoring into a unified procedural offering.
Strategic and corporate developments are another recurring theme. Recent news includes a definitive partnership with Theradaptive, Inc. granting ATEC exclusive U.S. commercial rights to OsteoAdapt®, an osteoinductive bone graft for spinal fusion built on AMP2™ protein technology. The company also issues releases about participation in major healthcare and medtech conferences, board-related updates, and inducement equity awards for new employees. This news page aggregates these items so readers can track how ATEC’s spine-only strategy, innovation pipeline, and financial trajectory evolve over time.
Alphatec Holdings, Inc. (ATEC) announced its participation in several upcoming investor conferences, including the Stifel Healthcare Conference on November 18, 2020, and the Canaccord Genuity Medical Technologies Forum on November 19, 2020. CEO Pat Miles and CFO Jeff Black will attend, engaging with registered investors. A live audio webcast of their presentations will be available on the company's Investor Relations page, with recordings accessible for 90 days. ATEC is dedicated to advancing spine surgery solutions through innovative medical devices and technology.
Alphatec Holdings (ATEC) reported a 43% year-over-year revenue growth, totaling $41.2 million for Q3 2020, marking the eighth consecutive quarter of double-digit growth. U.S. revenue reached $40.1 million, with a gross margin of 72.9%. The company successfully closed a follow-on offering generating $107.7 million to support growth initiatives. ATEC anticipates full-year 2020 revenue between $143.5 million and $146.0 million, with expected 25% growth in U.S. revenue for 2021, despite potential impacts from COVID-19.
Alphatec Holdings (ATEC) announced the launch of the InVictus™ MIS Tower system, enhancing minimally invasive spinal surgery options. This advanced fixation platform aims to treat complex pathologies with improved surgical adaptability. The InVictus Tower features innovative components such as low-profile removable towers and integrates with the SafeOp™ Neural InformatiX System for real-time nerve monitoring. CEO Pat Miles emphasized the commitment to developing solutions that enhance surgical outcomes, aiming for increased adoption and loyalty among surgeons.
Alphatec Holdings (ATEC) announced the closing of its public offering of 13,142,855 common shares, raising approximately $115 million at a price of $8.75 per share. This includes the full exercise of underwriters' options for an additional 1,714,285 shares. The offering was managed by Morgan Stanley and Cowen, among others. The shares were offered under a previously declared effective shelf registration statement with the SEC. ATEC aims to innovate spine surgery through its subsidiaries, focusing on safe and effective treatment solutions.
Alphatec Holdings, Inc. (ATEC) announced a public offering of 11,428,570 shares of its common stock priced at $8.75 per share, aiming for gross proceeds of approximately $100 million. The offering includes a 30-day option for underwriters to purchase an additional 1,714,285 shares. The transaction is expected to close on October 16, 2020, pending customary conditions. This offering is part of ATEC's strategy to enhance its capital for further innovative developments in spine surgery solutions.
Alphatec Holdings, Inc. (ATEC) has initiated an underwritten public offering of $85 million in common stock. Additionally, ATEC may grant underwriters a 30-day option to purchase up to 15% more shares. All shares are being sold by ATEC, and the offering is subject to market conditions. Morgan Stanley and Cowen are the joint book-running managers for this offering. The shares are offered under a shelf registration statement filed with the SEC. No assurance is provided regarding the completion or terms of the offering.
Alphatec Holdings, Inc. (ATEC) reported preliminary financial results for Q3 2020, forecasting a U.S. revenue increase of 41% to 43% compared to Q3 2019, with total revenue between $40.7 million and $41.1 million. This marks the eighth consecutive quarter of double-digit growth, driven by new product adoption and the SafeOp neuromonitoring system, which accounted for over 70% of revenue. Despite growth, the company anticipates an operating loss of $12.0 million to $13.5 million. ATEC had approximately $41 million in cash as of September 30, 2020.
Alphatec Holdings, Inc. (ATEC) announced the launch of the Sigma TLIF Access System and InVictus Modular Pedicle Screw, aimed at enhancing the transforaminal lumbar interbody fusion (TLIF) clinical experience. These innovations integrate with the SafeOp Neural InformatiX system for a comprehensive spinal surgery approach. The Sigma TLIF Access System improves visualization and reproducibility of minimally invasive surgeries, while the InVictus system enhances fixation reliability. Both systems will be showcased at the virtual North American Spine Society meeting.
Alphatec Holdings, Inc. (ATEC) has successfully performed over 500 prone transpsoas (PTP™) surgeries across the U.S., signaling a substantial advancement in spine surgery techniques. This new procedure streamlines surgical processes, enhancing operational efficiency and achieving improved spinal alignment. ATEC is set to commercially launch the PTP procedure in early Q4 2020. Key innovations include the PTP Patient Positioning System and other integrated tools, which collectively address challenges in lateral spine fusion and enhance predictability for surgeons.
Alphatec Holdings, Inc. (ATEC) announced that CEO Pat Miles will participate in virtual fireside chats at Morgan Stanley's Global Healthcare Conference on September 18, 2020, and Lake Street Capital Markets' Best Ideas Growth Conference on September 17, 2020. CFO Jeff Black will present at the H.C. Wainwright Annual Healthcare Conference on September 15, 2020. Live audio webcasts of the presentations and materials will be available on the investor relations page of ATEC's website. This initiative showcases ATEC's commitment to innovation in spine surgery and enhancing patient safety.